BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37949000)

  • 1. Low-grade endotoxemia in acute pulmonary embolism: Links with prothrombotic plasma fibrin clot phenotype.
    Ząbczyk M; Kruk A; Natorska J; Undas A
    Thromb Res; 2023 Dec; 232():70-76. PubMed ID: 37949000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk.
    Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A
    Sci Rep; 2020 Jul; 10(1):11433. PubMed ID: 32651425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolism.
    Stępień K; Ząbczyk M; Kopytek M; Natorska J; Zalewski J; Undas A
    J Thromb Thrombolysis; 2024 Feb; 57(2):248-259. PubMed ID: 37932588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
    Zabczyk M; Plens K; Wojtowicz W; Undas A
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):365-373. PubMed ID: 28062504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
    Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
    J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma fibrin clot proteomics in patients with acute pulmonary embolism: Association with clot properties.
    Bryk AH; Natorska J; Ząbczyk M; Zettl K; Wiśniewski JR; Undas A
    J Proteomics; 2020 Oct; 229():103946. PubMed ID: 32810596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype.
    Natorska J; Corral J; de la Morena-Barrio ME; Bravo-Pérez C; Bagoly Z; Bereczky Z; Treliński J; Witkowski M; Klajmon A; Undas A; Ząbczyk M
    Thromb Haemost; 2023 Sep; 123(9):880-891. PubMed ID: 37201530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
    Matusik PT; Matusik PS; Kornacewicz-Jach Z; Małecka B; Ząbek A; Undas A
    Int J Cardiol; 2017 Sep; 243():244-250. PubMed ID: 28571619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loose Fibrin Clot Structure and Increased Susceptibility to Lysis Characterize Patients with Central Acute Pulmonary Embolism: The Impact of Isolated Embolism.
    Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A
    Thromb Haemost; 2021 Apr; 121(4):529-537. PubMed ID: 33186996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.
    Paszek E; Malinowski KP; Ząbczyk M; Butenas S; Undas A
    Eur J Clin Invest; 2023 Sep; 53(9):e14007. PubMed ID: 37042848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right ventricular echocardiographic parameters associated with prothrombotic abnormalities in normotensive patients with acute pulmonary embolism.
    Janion-Sadowska A; Rostoff P; Ząbczyk M; Chrapek M; Janion M; Undas A
    Int J Cardiol; 2021 Jun; 333():195-201. PubMed ID: 33676943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Lactate Levels in Acute Pulmonary Embolism Are Associated with Prothrombotic Fibrin Clot Properties: Contribution of NETs Formation.
    Ząbczyk M; Natorska J; Janion-Sadowska A; Malinowski KP; Janion M; Undas A
    J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32235490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered fibrin clot properties are associated with the progression of chronic kidney disease in atrial fibrillation.
    Heleniak Z; Matusik PT; Undas A
    Thromb Res; 2024 Apr; 236():14-21. PubMed ID: 38387299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoprostane-8 and GDF-15 as novel markers of post-PE syndrome: Relation with prothrombotic factors.
    Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A
    Eur J Clin Invest; 2022 Jan; 52(1):e13660. PubMed ID: 34312860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen β chain and FXIII polymorphisms affect fibrin clot properties in acute pulmonary embolism.
    Klajmon A; Chmiel J; Ząbczyk M; Pociask E; Wypasek E; Malinowski KP; Undas A; Natorska J
    Eur J Clin Invest; 2022 Apr; 52(4):e13718. PubMed ID: 34783023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome.
    Siudut J; Grela M; Wypasek E; Plens K; Undas A
    J Thromb Haemost; 2016 Apr; 14(4):784-93. PubMed ID: 26786481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of enoxaparin on plasma fibrin clot properties and fibrin structure in patients with acute pulmonary embolism.
    Ząbczyk M; Natorska J; Malinowski KP; Undas A
    Vascul Pharmacol; 2020; 133-134():106783. PubMed ID: 32835836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism.
    Stubblefield WB; Alves NJ; Rondina MT; Kline JA
    PLoS One; 2016; 11(2):e0148747. PubMed ID: 26866684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.